HCW Biologics jumps on license agreement for immunotherapeutic product candidate

seekingalpha11-18

sanjeri/E+ via Getty Images U.S.-based HCW Biologics' (NASDAQ:HCWB) shares rallied in Monday's premarket trade, driven by a license, research and co-development agreement with China's WY Biotech for ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2484622184?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1131583289/image_1131583289.jpg?io=getty-c-w750","is_english":true,"pubTime":"2024-11-18 20:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484622184","market":"other","top_or_hot":-1,"title":"HCW Biologics jumps on license agreement for immunotherapeutic product candidate","media":"seekingalpha","content":"<div>\n<p>sanjeri/E+ via Getty Images  U.S.-based HCW Biologics' (NASDAQ:HCWB) shares rallied in Monday's premarket trade, driven by a license, research and co-development agreement with China's WY Biotech for ...</p>\n\n<a href=\"https://seekingalpha.com/news/4301703-hcw-biologics-jumps-on-license-agreement-for-immunotherapeutic-product-candidate-with-wy-biotech\">Source Link</a>\n\n</div>\n","source":"seekingalpha_trending_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HCW Biologics jumps on license agreement for immunotherapeutic product candidate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHCW Biologics jumps on license agreement for immunotherapeutic product candidate\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-18 20:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4301703-hcw-biologics-jumps-on-license-agreement-for-immunotherapeutic-product-candidate-with-wy-biotech><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>sanjeri/E+ via Getty Images  U.S.-based HCW Biologics' (NASDAQ:HCWB) shares rallied in Monday's premarket trade, driven by a license, research and co-development agreement with China's WY Biotech for ...</p>\n\n<a href=\"https://seekingalpha.com/news/4301703-hcw-biologics-jumps-on-license-agreement-for-immunotherapeutic-product-candidate-with-wy-biotech\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_MNQ","symbol_name":"微型NQ100指数","start_time":0,"source_url":"https://seekingalpha.com/news/4301703-hcw-biologics-jumps-on-license-agreement-for-immunotherapeutic-product-candidate-with-wy-biotech","article_id":"2484622184","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1131583289/image_1131583289.jpg?io=getty-c-w750"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484622184","pubTimestamp":1731931976,"sourceInfo":{"source_id":"seekingalpha_trending_news","name":"Seeking Alpha Trending News"},"weMediaInfo":null,"summary":"sanjeri/E+ via Getty Images  U.S.-based HCW Biologics'  shares rallied in Monday's premarket trade, driven by a license, research and co-development agreement with China's WY Biotech for one of its new proprietary preclinical molecules. HCW Biologics  up +114.84% premarket to $0.64. Key terms of the","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QID":"纳指两倍做空ETF","BK4139":"生物科技","BK4539":"次新股","SQQQ":"纳指三倍做空ETF","HCWB":"HCW Biologics Inc.","PSQ":"纳指反向ETF","QLD":"纳指两倍做多ETF","TQQQ":"纳指三倍做多ETF",".IXIC":"NASDAQ Composite"},"translate_title":"HCW Biologics签署免疫治疗候选产品许可协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCWB":1,".IXIC":0.65,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"sanjeri/E+ via Getty Images  U.S.-based HCW Biologics' (NASDAQ:HCWB) shares rallied in Monday's premarket trade, driven by a license, research and co-development agreement with China's WY Biotech for one of its new proprietary preclinical molecules. HCW Biologics (HCWB) up +114.84% premarket to $0.64. Key terms of the","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484622184"}